|4Jun 21, 9:56 PM ET

Protagenic Therapeutics, Inc.\new 4

4 · Protagenic Therapeutics, Inc.\new · Filed Jun 21, 2016

Insider Transaction Report

Form 4
Period: 2016-06-17
Arrow Alexander K.
Chief Financial Officer
Transactions
  • Award

    NSO Stock Option

    2016-06-17$1.25/sh+140,000$175,000358,260 total
Footnotes (1)
  • [F1]Dollar figure listed indicates exercise price of the stock option grant.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4